Job/Unit: O42391
/KAP1
Date: 21-05-14 18:07:32
Pages: 9
Synthesis and Reactivity of Porphyrinyl Grignard Reagents
120.12, 120.09, 102.36, 72.04, 35.16, 35.14, 31.85, 31.83 ppm. UV/
Synthesis of 9Ni and 10Ni: A Schlenk tube containing NiII β,βЈ-
diiodoporphyrin 7Ni (118 mg, 100 μmol) was purged with argon
Vis (CH2Cl2): λmax (ε [m–1 cm–1])
=
413 (2.6ϫ105), 525 nm
(1.9ϫ104). HRMS (APCI-TOF): calcd for C69H78ON458Ni and then charged with dry THF (2.0 mL). After the solution had
1036.5524 [M]–; found 1036.5531.
been cooled to –40 °C, iPrMgCl·LiCl (1.0 m solution in THF,
0.30 mL, 300 μmol) was slowly added, and then the reaction mix-
ture was stirred for 2 h at –40 °C. DMF (32 μL, 400 μmol) was
added to the resulting red solution. After having been stirred for
2 h at room temperature, the reaction mixture was quenched with
a sufficient amount of NH4Cl solution, extracted with CH2Cl2,
washed with brine, and dried with Na2SO4. After removal of the
solvent in vacuo, the residue was separated by silica gel chromatog-
raphy with elution with CH2Cl2/hexane. Recrystallization from
CH2Cl2/methanol gave 10Ni (76 mg, 77 μmol, 77%). For the syn-
thesis of 9Ni (88 mg, 94 μmol, 94%), D2O (ca. 0.1 mL) was added
instead of DMF and the resulting mixture was stirred for 5 min.
1
Compound 5Ni: H NMR (600 MHz, CDCl3, 60 °C): δ = 10.58 (s,
1 H, meso), 9.14 (d, J = 4.6 Hz, 1 H, β), 8.88 (d, J = 4.6 Hz, 1 H,
β), 8.77 (m, 5 H, β), 7.90 (m, 4 H, Ar-o), 7.87 (d, J = 1.8 Hz, 2 H,
Ar-o), 7.75 (m, 2 H, Ar-p), 7.72 (t, J = 1.8 Hz, 1 H, Ar-p), 2.72 (d,
J = 13.3 Hz, 2 H, cyclohexyl), 2.55–2.49 (m, 2 H, cyclohexyl), 2.49
(s, 1 H, OH), 2.19–2.13 (m, 2 H, cyclohexyl), 1.93–1.85 (m, 3 H,
cyclohexyl), 1.59–1.52 (m, 1 H, cyclohexyl), 1.51 (s, 18 H, tert-
butyl), 1.50 (s, 18 H, tert-butyl), 1.47 (s, 18 H, tert-butyl) ppm. 13
C
NMR (151 MHz, CDCl3, 25 °C): δ = 151.76, 149.13, 149.10,
149.02, 143.03, 142.93, 142.88, 142.54, 142.49, 142.43, 140.64,
140.52, 140.28, 140.23, 140.12, 132.74, 132.55, 132.43, 132.26,
132.21, 129.28, 128.92, 128.83, 121.24, 121.18, 121.11, 120.49,
119.92, 119.40, 104.83, 73.12, 40.80, 35.19, 35.16, 35.13, 31.87,
31.84, 26.11, 22.76 ppm. UV/Vis (CH2Cl2): λmax (ε [m–1 cm–1]) =
413 (2.6ϫ105), 524 nm (1.9ϫ104). HRMS (APCI-TOF): calcd for
C68H82ON458Ni 1028.5837 [M]–; found 1028.5846.
1
Compound 9Ni: H NMR (600 MHz, CDCl3, 25 °C): δ = 9.83 (s, 1
H, meso), 8.93 (s, 2 H, β), 8.83 (m, 4 H, β), 7.90 (d, J = 1.8 Hz, 4
H, Ar-o), 7.87 (d, J = 1.8 Hz, 2 H, Ar-o), 7.74 (t, J = 1.8 Hz, 2 H,
Ar-p), 7.71 (t, J = 1.8 Hz, 1 H, Ar-p), 1.49 (s, 36 H, tert-butyl),
1.46 (s, 18 H, tert-butyl) ppm. HRMS (APCI-TOF): calcd for
C62H70D2N458Ni 932.5231 [M]–; found 932.5235.
1
Compound 6Ni: H NMR (600 MHz, CDCl3, 25 °C): δ = 11.01 (s,
Compound 10Ni: 1H NMR (600 MHz, CDCl3, 25 °C): δ = 11.38 (s,
1 H, meso), 11.16 (s, 1 H, formyl), 9.38 (s, 2 H, β), 8.77 (d, J =
4.6 Hz, 2 H, β), 8.75 (d, J = 4.6 Hz, 2 H, β), 7.84 (d, J = 1.8 Hz,
4 H, Ar-o), 7.81 (d, J = 1.8 Hz, 2 H, Ar-o), 7.73 (t, J = 1.8 Hz, 2
H, Ar-p), 7.73 (t, J = 1.8 Hz, 1 H, Ar-p), 1.50 (s, 36 H, tert-butyl),
1.46 (s, 18 H, tert-butyl) ppm. 13C NMR (151 MHz, CDCl3, 25 °C):
δ = 187.45, 149.54, 149.41, 144.83, 144.15, 140.90, 140.10, 139.59,
139.32, 139.00, 138.76, 133.81, 133.59, 128.84, 128.64, 122.85,
122.02, 121.69, 103.76, 35.19, 35.16, 31.82, 31.80 ppm. UV/Vis
(CH2Cl2): λmax (ε [m–1 cm–1]) = 441 (2.0ϫ105), 551 (1.4ϫ104), 592
(1.1ϫ104). HRMS (APCI-TOF): calcd for C64H72O2N458Ni
986.5003 [M]–; found 986.5032.
1 H, formyl), 10.69 (s, 1 H, meso), 9.37 (s, 1 H, β), 9.17 (d, J =
4.6 Hz, 1 H, β), 8.86 (d, J = 4.6 Hz, 1 H, β), 8.78 (m, 3 H, β), 8.74
(d, J = 4.9 Hz, 1 H, β), 7.88 (s, 2 H, Ar-o), 7.86 (s, 2 H, Ar-o), 7.83
(s, 2 H, Ar-o), 7.78 (s, 1 H, Ar-p), 7.74 (s, 1 H, Ar-p), 7.72 (s, 1 H,
Ar-p), 1.50 (s, 18 H, tert-butyl), 1.49 (s, 18 H, tert-butyl), 1.46 (s,
18 H, tert-butyl) ppm. 13C NMR (151 MHz, CDCl3, 25 °C): δ =
188.04, 149.31, 149.21, 144.72, 144.64, 144.41, 143.75, 143.50,
142.76, 140.20, 139.77, 139.63, 139.52, 139.47, 139.34, 137.32,
134.00, 133.50, 133.46, 133.21, 133.06, 132.54, 128.87, 128.72,
122.99, 121.79, 121.43, 121.22, 119.84, 104.71, 35.18, 35.17, 35.14,
31.83, 31.80 ppm. UV/Vis (CH2Cl2): λmax (ε [m–1 cm–1]) = 426
(2.1ϫ105), 535 (1.3ϫ104), 577 (1.2ϫ104). HRMS (APCI-TOF):
calcd for C63H72ON458Ni 958.5054 [M]–; found 958.5080.
Synthesis of 13Ni–16Ni: This procedure is similar to that used for
the synthesis of 3Ni–6Ni except for the starting material.
Synthesis of 3Zn and 5Zn: This procedure is similar to that used
for the synthesis of 3Ni–6Ni except that iodine–magnesium ex-
change of 1Zn was performed at –80 °C. Recrystallization from
CH2Cl2/methanol gave 3Zn (85 mg, 90 μmol, 90%) and 5Zn
(70 mg, 68 μmol, 68%).
1
Compound 13Ni: H NMR (600 MHz, CDCl3, 25 °C): δ = 9.14 (d,
J = 4.6 Hz, 2 H, β), 8.93 (d, J = 4.6 Hz, 2 H, β), 8.84 (m, 4 H, β),
7.90 (d, J = 1.8 Hz, 4 H, Ar-o), 7.88 (d, J = 1.8 Hz, 2 H, Ar-o),
7.74 (t, J = 1.8 Hz, 2 H, Ar-p), 7.71 (t, J = 1.8 Hz, 1 H, Ar-p), 1.49
(s, 36 H, tert-butyl), 1.46 (s, 18 H, tert-butyl) ppm. HRMS (APCI-
TOF): calcd for C62H71DN458Ni 931.5168 [M]–; found 931.5196.
1
Compound 3Zn: H NMR (600 MHz, CDCl3, 25 °C): δ = 10.27 (s,
1 H, meso), 9.42 (d, J = 4.7 Hz, 1 H, β), 8.93 (m, 2 H, β), 9.06 (d,
J = 4.6 Hz, 2 H, β), 9.03 (d, J = 4.6 Hz, 2 H, β), 8.12 (d, J =
1.9 Hz, 4 H, Ar-o), 8.09 (d, J = 2.0 Hz, 2 H, Ar-o), 7.82 (t, J =
1.9 Hz, 2 H, Ar-p), 7.79 (t, J = 2.0 Hz, 1 H, Ar-p), 1.55 (s, 36 H,
tert-butyl), 1.52 (s, 18 H, tert-butyl) ppm. HRMS (APCI-TOF):
calcd for C62H71DN464Zn 937.5106 [M]–; found 937.5120.
1
Compound 14Ni: H NMR (600 MHz, CDCl3, 25 °C): δ = 9.28 (d,
J = 5.0 Hz, 2 H, β), 8.76 (m, 4 H, β), 8.74 (d, J = 4.6 Hz, 2 H, β),
8.01 (d, J = 3.7 Hz, 1 H, benzyl), 7.83 (d, J = 1.8 Hz, 2 H, Ar-o),
7.81 (d, J = 1.3 Hz, 4 H, Ar-o), 7.69 (s, 3 H, Ar-p), 7.57 (d, J =
7.8 Hz, 2 H, Ph), 7.28 (d, J = 7.8 Hz, 2 H, Ph), 7.23 (d, J = 7.8 Hz,
1 H, Ph), 3.36 (d, J = 3.7 Hz, 1 H, OH), 1.45 (s, 54 H, tert-
butyl) ppm. 13C NMR (151 MHz, CDCl3, 25 °C): δ = 149.12,
147.02, 142.81, 142.40, 142.02, 141.82, 139.3, 133.63, 132.83,
132.44, 130.62, 128.70, 128.26, 126.82, 126.51, 121.31, 120.85,
120.04, 116.58, 75.13, 35.12, 31.80 ppm. UV/Vis (CH2Cl2): λmax
(ε [m–1 cm–1]) = 418 (2.5ϫ105), 533 nm (1.7ϫ104). HRMS (APCI-
TOF): calcd for C64H72O2N458Ni 1036.5524 [M]–; found 1036.5546.
1
Compound 5Zn: H NMR (600 MHz, CDCl3, 60 °C): δ = 10.84 (s,
1 H, meso), 9.41 (d, J = 4.6 Hz, 1 H, β), 9.11 (d, J = 4.6 Hz, 1 H,
β), 9.03 (m, 3 H, β), 8.99 (d, J = 4.6 Hz, 1 H, β), 8.85 (s, 1 H, β),
8.12 (m, 4 H, Ar-o), 8.09 (d, J = 1.8 Hz, 2 H, Ar-o), 7.83 (m, 2 H,
Ar-p), 7.81 (br. s, 1 H, Ar-p), 2.72 (d, J = 13.3 Hz, 2 H, cyclohexyl),
2.55–2.49 (m, 2 H, cyclohexyl), 2.43 (s, 1 H, OH), 2.14–2.09 (m, 2
H, cyclohexyl), 1.94–1.86 (m, 3 H, cyclohexyl), 1.58 (s, 18 H, tert-
butyl), 1.56 (s, 18 H, tert-butyl), 1.54 (s, 18 H, tert-butyl) ppm. 13
C
1
NMR (151 MHz, CDCl3, 60 °C): δ = 150.76, 150.68, 150.30,
150.14, 149.71, 148.91, 148.88, 148.78, 148.31, 147.78, 142.39,
142.22, 142.13, 132.60, 132.40, 132.27, 132.20, 132.08, 131.93,
130.37, 129.85, 129.74, 129.27, 122.84, 122.17, 121.67, 121.02,
120.99, 120.81, 106.14, 73.24, 41.07, 35.31, 35.28, 35.21, 32.00,
Compound 15Ni: H NMR (600 MHz, CDCl3, 25 °C): δ = 9.67 (d,
J = 5.0 Hz, 2 H, β), 8.67 (m, 4 H, β), 8.60 (d, J = 5.0 Hz, 2 H, β),
7.79 (br. s, 2 H, Ar-o), 7.76 (br. s, 4 H, Ar-o), 7.67 (m, 3 H, Ar-p),
3.37 (m, 2 H, cyclohexyl), 2.46 (d, J = 14.2 Hz, 2 H, cyclohexyl),
2.14–2.06 (m, 2 H, cyclohexyl), 2.01 (br. d, 1 H, cyclohexyl), 1.91
21.97, 26.13, 22.79 ppm. UV/Vis (CH2Cl2): λmax (ε [m–1 cm–1]) = (m, 2 H, cyclohexyl), 1.76 (m, 1 H, cyclohexyl), 1.58 (s, 1 H, OH),
418 (6.1ϫ105), 545 nm (2.4ϫ104). HRMS (APCI-TOF): calcd for
1.45 (s, 36 H, tert-butyl), 1.43 (s, 18 H, tert-butyl) ppm. 13C NMR
(151 MHz, CDCl3, 25 °C): δ = 149.10, 141.99, 141.45, 139.90,
C68H82ON464Zn 1034.5775 [M]–; found 1034.5788.
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5